Back

Frequency, course and prognostic yield of valvular heart disease in the general population- Results from the STAAB cohort study

11 December 2024 (00:00 - 16:00)
Organised by: Logo
Congress Presentation Part of: What's new in valvular heart disease Valvular Heart Disease EACVI Premium Access EuroEcho-Imaging 2024 European Association of Cardiovascular Imaging (EACVI)

About the speaker

Photo
Doctor Mengmeng Chen

University Hospital Wuerzburg, Wuerzburg (Germany)

3 More presentations in this session

Presentation thumbnail
Prediction of mortality and heart failure admission with the mitraScore after percutaneous mitral valve repair: an external validation study
Mr L. Barreiro Mesa (Cordoba, ES)
Abstract Slides Video
Presentation thumbnail
Left ventricular pressure-strain-volume-loop and myocardial work patterns in asymptomatic severe aortic regurgitation with early disease decompensation
Doctor E. de Oliveira (Aalst, BE)
Abstract Slides Video
Presentation thumbnail
Prognostic role of right atrial strain in patients with secondary tricuspid regurgitation: insights from the CARE-TR registry
Doctor L. Lupi (Brescia, IT)
Abstract Slides Video

Access the full session

Session thumbnail
What's new in valvular heart disease
Video

The Event

Event poster

EuroEcho-Imaging 2024

11 December - 13 December 2024
You may be interested in
thumbnail
Congress Presentation
Prevalence of valvular heart disease in the general population: results from the population based STAAB cohort study
thumbnail
Congress Presentation
Sex-specific patterns in worldwide burden of non-rheumatic degenerative mitral valve disease between 1990 and 2021, results from the Global Burden of Disease Study 2021
thumbnail
Congress Presentation
East Asian-specific genome-wide association study and cross-ancestry meta-analysis reveal the genetic foundations of valvular heart disease and its subtypes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources